Beyond the BENEFITs: An Updated Review of the Clinical Use of Belatacept: HomeStudy
At the completion of the activity, the participant will be able to:
Define current first-line maintenance immunosuppression strategies in solid organ transplantation
List the advantages and disadvantages of belatacept with calcineurin inhibitors
Describe recent literature for belatacept maintenance immunosuppression in transplant recipients groups previously excluded from hallmark trials.
List key literature findings that can be utilized in clinical practice
- Marina Juan/Solid Organ Transplant PGY-2 Pharmacy Resident/PharmD
- Dr. Marina Juan, originally from New York City, obtained her PharmD from the Albany College of Pharmacy and Health Sciences. She completed PGY-1 pharmacy residency training at Montefiore Medical Center and is currently at the Mount Sinai Hospital for PGY-2 residency training in Solid Organ Transplantation. During her spare time, she enjoys exploring the restaurants of New York City with friends and bringing to life artistic project
ACPE UAN # 0042-9999-23-087-H01-P
- 1.00 ACPEThe Arnold & Marie Schwartz College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.